RxDoctor Payments Data

Miguel Rivera, MD

Otolaryngology/Facial Plastic Surgery · Brandon, FLNPI 1699860122

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.6% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 18.1% — the pattern of someone who eats at a lot of different presentations.

$3,100in general payments, 2019–2025

Across 83 payments — averaging $37.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$561
  • Regeneron Healthcare Solutions, Inc.$500
  • Optinose US, Inc.$364
  • Acclarent, Inc$346
  • Medtronic$292
  • Aerin Medical Inc.$193
  • plus $845 from 15 others

What the payments were for

  • Food & beverage$2,86993%
  • Education$2317%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,100 in reported general payments places this provider in the 60th percentile of 48 otolaryngology/facial plastic surgery providers in Florida.

See all otolaryngology/facial plastic surgery providers in Florida

Medicare billing

Part B allowed, 2024
$96,236
Medicare patients
278
Services billed
1,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab25$103,880
Dupixent SyringeDupilumab24$98,161
Epinephrine46$7,672
Fluticasone Propionate399$5,674
Fluocinolone Acetonide Oil41$2,018
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth19$1,875
Ipratropium Bromide62$1,497
Famotidine145$1,480
Azelastine Hcl40$1,319
ValacyclovirValacyclovir Hcl28$1,288
Omeprazole97$815
Levocetirizine Dihydrochloride30$731
Mometasone Furoate11$388
Nystatin21$324
Esomeprazole Magnesium13$306

Paid to pharmacies, not to this prescriber.

Other otolaryngology/facial plastic surgery in Brandon

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →